about
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisCharacterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cellsDonor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.Donor cell myeloid sarcoma.Revisiting the hallmarks of cancer.Low numbers of pre-leukemic fusion genes are frequently present in umbilical cord blood without affecting DNA damage response.Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response.Nice neighborhood: emerging concepts of the stem cell niche.Blood loses it when nerves go badImpact of donor age on outcome after allogeneic hematopoietic cell transplantation.Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donorIncidence of common preleukemic gene fusions in umbilical cord blood in Slovak population.A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma.Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challengesDonor Cell Myeloid Sarcoma in an Umbilical Cord Transplant Patient: A Case Report and a Review of the Literature.Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemiaNormal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutationsBone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticistsDonor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML.Normal and leukemic stem cell niches: insights and therapeutic opportunities.A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML.PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.Complexity of bone marrow hematopoietic stem cell niche.Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.Donor-Cell Origin High-Risk Myelodysplastic Syndrome Synchronous with an Intracranial Meningioma-Like Tumor, 8 Years after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.Recurrent disease or donor cell leukemia?: Brain teaser after allogeneic bone marrow transplantationDevelopment of donor cell leukemia following peripheral blood stem cell transplantation for severe aplastic anemia: A case report.Donor-associated malignancy in kidney transplant patientsSuccessful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation.BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia.Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement.Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient.Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.Acute Megakaryoblastic Leukemia Developing as Donor Cell Leukemia after Umbilical Cord Blood Transplantation.Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant.Identification of regulators of germ stem cell enwrapment by its niche in C. elegans.Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.
P2860
Q26774212-C1594DD0-691F-4ACB-92DA-FBBFA1024EA7Q27334529-9A5526AD-527C-4135-8107-21B49BC84DFAQ33410208-272573E8-B948-4A0E-8FEF-708FB76FEA4EQ33563239-424D57B2-414F-4615-9351-BD16B094037FQ33732986-CA88EE91-B020-40B0-A7DA-53B4EDB77122Q33829330-387C84DE-8F34-4328-9E0C-61B421FF6222Q33903139-F6DBF344-EE78-4115-B727-478702F13A8AQ34165273-B55C88C5-F199-47E9-8245-842F3618AB55Q34289943-B24ABACD-F04A-4F5C-9DF3-C764B4F54261Q34859147-4DAB9FAE-B3F2-49E6-B166-ABC2D7F97DA7Q35074246-E89C4332-7BD5-4FF4-A0F1-03F5621827D3Q35118597-DC611698-F566-4DDF-B2E7-027C60BB700BQ35679594-E378C108-9D83-4571-A05E-303C0326DBC2Q36266642-B071EE00-24AE-412E-98DA-0E5FD7C39D93Q36448540-FC5D2F42-7F26-4D4A-946F-1480F3F6607EQ36736745-988E71C6-228D-4302-9095-1E10A7486AFEQ37046277-99EE619E-CDFB-4F66-8CBB-D8B726B2EAC4Q37094051-C9973A46-B9A6-4CB5-92EB-EE3786A9894BQ37160220-630BAC8F-FA67-4657-A68A-4B474AC68599Q37239107-38773597-7A0F-4E30-AA44-E13C3D449F3BQ37681572-F54490B7-145F-48AF-821F-A113D02DB616Q38369894-F7E4C749-B2C7-41F0-914C-58272517D938Q38737985-8F026024-2303-4B65-98EB-8A5E39527E47Q38835020-8DD94D6D-5CF9-4040-9DA4-0608BE343F2CQ39324033-63681A26-CD88-4D31-B41A-56900C88D0EFQ39517136-03C21CA4-1B17-4238-BC26-81C577C71C18Q40004270-D7729DAA-F229-4A58-BAD1-F19FFCC98ADEQ41439610-83B2D949-BE7F-4E01-BCFF-C3CA0B7A4EDAQ41827219-DB02829E-CDE1-46BA-98CD-63432AA9672BQ42157356-CCEF7BA4-A8AF-4E0F-8C38-326FE8077368Q42572911-025CD2C7-BDCC-43E2-872C-1F35027D6753Q44140110-C06852FD-B46A-40D1-9DA9-0FAB9C597473Q46938568-6C016A3A-03D2-4EFA-AEC4-C24B797C076EQ47786136-D9D486CF-61F9-4178-9BEF-8567D8830313Q48355093-442F9D46-D3C5-49AC-B28E-AC8E4DF401ECQ49562964-9B7985DB-A16A-4DA6-9361-CD7F77210697Q49901789-A85F133F-48A4-423A-AAF5-67499770952EQ50058694-9676E625-0CB0-481A-98AC-AF021C069AF6Q50924822-C2BED8CC-5D98-424E-9385-C5B2C14DB235Q50966214-E29F91B3-7D1A-431B-BB81-52FB3881B292
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Donor cell leukemia: a review.
@ast
Donor cell leukemia: a review.
@en
type
label
Donor cell leukemia: a review.
@ast
Donor cell leukemia: a review.
@en
prefLabel
Donor cell leukemia: a review.
@ast
Donor cell leukemia: a review.
@en
P1476
Donor cell leukemia: a review.
@en
P304
P356
10.1016/J.BBMT.2010.10.010
P577
2010-10-15T00:00:00Z